TransGenRx, Inc.
5Patents
4Active
5Granted
43Portfolio score
Filing activity: Jun 26, 2003 → Nov 8, 2010 · 4 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7608451B2 | Gene regulation in transgenic animals using a transposon-based vector | Emerging Cross-Sectional Technologies | 100 | Active |
| US8071364B2 | Gene therapy using transposon-based vectors | Chemistry; Metallurgy | 11 | Active |
| US7527966B2 | Gene regulation in transgenic animals using a transposon-based vector | Emerging Cross-Sectional Technologies | 10 | Expired |
| US8236294B2 | Gene therapy using transposon-based vectors | Chemistry; Metallurgy | 10 | Active |
| US8283518B2 | Administration of transposon-based vectors to reproductive organs | Chemistry; Metallurgy | 5 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.